AgPlus Holdings Limited Holdings (‘AgPlus’), the ultra sensitive point-of-care electrochemical diagnostic business, announces the appointment of Dr Tito Bacarese-Hamilton as a Non Executive Director of the Company.

He joins AgPlus from EKF Diagnostics where he was Chief Technology Officer with responsibility for the development and commercial launch of new products and platforms. In addition he was the principal interface with manufacturing operations for the production of new products and platforms critical to EKF’s strategic growth objectives.

Prior to that role, from 2005-2014 Tito was Vice President responsible for research and development at Johnson & Johnson’s (NYSE: JNJ) Diabetes Care Franchise where he was responsible for the development and scale-up of new, multi billion dollar sensing platforms.

Tito is a clinical biochemist by training and brings more than 25 years of research and industrial experience in the medical and life sciences sector. He has a broad-based background in medical research and diagnostic product development, biotechnology, drug development programmes and general management. He is an acknowledged expert in the field of in vitro diagnostics with a proven track record of repeatedly and successfully turning innovative technology into revenue-generating platforms.

For further details download our Press release: Dr Bacarese-Hamilton NED 160229